Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Adrian S. Ray et al.|Circulation|2025Cited by 26
Abstract 4139465: Integrin α5β1 represents a novel therapeutic target to improve vascular remodeling in pulmonary arterial hypertensionSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Circulation|2024Cited by 1
Implication of Integrin α5β1 in right ventricular failure associated with pulmonary arterial hypertensionSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Unknown|2024Cited by 0
Abstract 4143098: Development and characterization of an ex vivo human precision-cut lung slice (hPCLS) system for target validation for pulmonary arterial hypertensionHae Jin Kim, Bryan Goodwin, Muzaffar Akram et al.|Circulation|2024Cited by 0
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0